PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$0.92
+0.06 (+7.39%)
As of Feb 8, 2:29 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.43M 2.52M 2.31M
Net Income 150.5K 215.1K 194.2K
EPS
Profit Margin 6.2% 8.5% 8.4%
Rev Growth +21.7% -7.9% -0.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.21M 3.29M 3.47M
Total Equity 4.23M 4.11M 4.07M
D/E Ratio 0.76 0.80 0.85
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 295.2K 302.7K 296.9K
Free Cash Flow 147.2K 165.8K 140.8K